HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JIANGXI BIO

6.370

+0.0701.11%

Volume:1.46M

Turnover:9.36M

Market Cap:1.96B

PE:- -

High:7.060

Open:6.300

Low:6.020

Close:6.300

52wk High:10.750

52wk Low:6.020

Shares:308.38M

HK Float Shares:307.00M

Volume Ratio:0.09

T/O Rate:0.47%

Dividend:- -

Dividend Rate:- -

ROE:21.04%

ROA:12.08%

PB:3.41

PE(LYR):- -

PS:7.22

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Jiangxi Bio Unit Wins China Nod for Veterinary Tetanus Antitoxin

MT Newswires Live

Movement Alert｜Jiangxi Biologics Rises 9.52% in Regular Trading, Subsidiary Obtains Veterinary Tetanus Antitoxin Product Approval

JIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin

Jiangxi Bio Gains Regulatory Green Light for Veterinary Tetanus Antitoxin, Expanding Animal Health Pipeline

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/06915"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06915","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06915\",,,,,undefined,":{"symbol":"06915","market":"HK","secType":"STK","nameCN":"JIANGXI BIO","latestPrice":6.37,"timestamp":1783066093470,"preClose":6.3,"halted":0,"volume":1455500,"delay":0,"changeRate":0.011111111111111157,"floatShares":307000000,"shares":308377319,"eps":0,"marketStatus":"Closed","change":0.07,"latestTime":"07-03 16:08:13","open":6.3,"high":7.06,"low":6.02,"amount":9364125,"amplitude":0.165079,"askPrice":6.37,"askSize":10500,"bidPrice":6.31,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.34,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":5,"adr":0,"listingDate":1782748800000,"exchange":"SEHK","adjPreClose":6.3,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.090463,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06915\",,,,,undefined,":{"symbol":"06915","floatShares":307000000,"roa":"12.08%","roe":"21.04%","lyrEps":0,"volumeRatio":0.090463,"shares":308377319,"dividePrice":0,"high":7.06,"amplitude":0.165079,"preClose":6.3,"low":6.02,"week52Low":6.02,"pbRate":"3.41","psRate":"7.22","week52High":10.75,"institutionHeld":0,"latestPrice":6.37,"committee":-0.826087,"eps":0,"divideRate":0,"volume":1455500,"delay":0,"ttmEps":0.34,"open":6.3,"prevYearClose":11.2,"prevWeekClose":11.2,"prevMonthClose":9.78,"prevQuarterClose":9.78,"fiveDayClose":11.2,"twentyDayClose":11.2,"sixtyDayClose":11.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06915\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06915\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06915\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06915\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06915","date":"2026-07-02","current":18.529412,"percent":1,"low":17.750558,"twenty":17.750558,"median":17.750558,"eighty":17.750558,"high":17.750558,"avg":17.750558,"sd":0,"marketCap":1942777109},"quantilePoints":[{"date":"2026-07-02","current":17.750558,"twenty":17.750558,"median":17.750558,"eighty":17.750558,"marketCap":1942777109}],"updateTime":1783046906882},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06915\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2648653305","title":"Jiangxi Bio Unit Wins China Nod for Veterinary Tetanus Antitoxin","url":"https://stock-news.laohu8.com/highlight/detail?id=2648653305","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648653305?lang=en_us&edition=fundamental","pubTime":"2026-07-03 12:51","pubTimestamp":1783054273,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products'  wholly owned subsidiary, Chifeng Bo-en Pharmaceutical, received an approval certificate from Chinese regulators for its veterinary tetanus antitoxin, according to a Friday Hong Kong bourse filing.The product is used to prevent and treat tetanus infections in animals by neutralizing tetanus toxin and providing passive immune protection to animals at risk of infection.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185086992","title":"Movement Alert｜Jiangxi Biologics Rises 9.52% in Regular Trading, Subsidiary Obtains Veterinary Tetanus Antitoxin Product Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1185086992","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185086992?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:58","pubTimestamp":1783043903,"startTime":"0","endTime":"0","summary":"On July 3, Jiangxi Biologics rose 9.52% in regular trading, trading at HKD 6.82/share, with turnover of HKD 1.8971 million.On the news front, the company announced that its wholly-owned subsidiary...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131987482","title":"JIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin","url":"https://stock-news.laohu8.com/highlight/detail?id=1131987482","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131987482?lang=en_us&edition=fundamental","pubTime":"2026-07-03 06:57","pubTimestamp":1783033063,"startTime":"0","endTime":"0","summary":"The company JIANGXI BIO (ASX: 06915) has announced that its wholly-owned subsidiary, Chifeng Boen Pharmaceutical Co., Ltd., has recently obtained the official approval document for its veterinary...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106495850","title":"Jiangxi Bio Gains Regulatory Green Light for Veterinary Tetanus Antitoxin, Expanding Animal Health Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1106495850","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106495850?lang=en_us&edition=fundamental","pubTime":"2026-07-03 06:43","pubTimestamp":1783032232,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) announced that its wholly owned subsidiary, Chifeng Bo-en Pharmaceutical Co., Ltd., has secured the Approval Certificate of Veterinary Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/06915\",params:#limit:6,delay:false,,,undefined,":[]}}